BC
IDXX icon

BDFS Capital’s Idexx Laboratories IDXX Stock Holding History

BDFS Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538K Buy
1,022
+117
+13% +$65.6K 0.23% 76
2026
Q1 		$509K Sell
905
-87
-9% -$55.8K 0.24% 79
2025
Q4 		$671K Buy
+992
New +$676K 0.34% 49

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BDFS Capital's IDXX Position: Q2 2026 in Review

BDFS Capital increased its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, buying an estimated $65.6K and bringing the position to 1,022 shares worth $538K. The position accounts for 0.23% of the portfolio, ranked #76.

BDFS Capital first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $671K in Q4 2025. 1,292 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • BDFS Capital held 1,022 shares of Idexx Laboratories worth $538K as of Q2 2026.
  • BDFS Capital bought 117 Idexx Laboratories shares in Q2 2026, an estimated $65.6K.
  • Idexx Laboratories made up 0.23% of BDFS Capital's portfolio in Q2 2026, its #76 holding.
  • BDFS Capital first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • BDFS Capital's Idexx Laboratories position peaked at $671K in Q4 2025.
  • 1,292 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on BDFS Capital's 13F filing for Q2 2026, filed 15 Jul 2026.